Hilary Yu-heng Ma, MD
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Health Disparities Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Center Medical Director, MD Anderson Oncology Program at Lyndon B. Johnson (LBJ) Hospital, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Attending Physician, Lyndon B. Johnson (LBJ) Hospital, Harris Health, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor, Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2002 | University of California, San Diego, La Jolla, CA, US, Medicine, MD |
| 1998 | University of California, Irvine, Irvine, CA, US, Biological Sciences, BS |
Postgraduate Training
| 2022-2022 | LEADing Teams Leadership Core Program, Leadership Institute, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2019-2019 | Clinical Safety & Effectiveness Educational Program, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2018-2018 | Project Extension for Community Healthcare Outcomes (ECHO) Training, Superhub at MD Anderson, The Unviversity of Texas MD Anderson Cancer Center, Houston, TX |
| 2006-2009 | Clinical Fellowship, Hematology & Medical Oncology, New York University (NYU) School of Medicine, New York, NY |
| 2005-2006 | Research Fellowship, Neuro-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD |
| 2002-2005 | Clinical Residency, Internal Medicine, St Mary's Hospital; San Francisco General Hospital; University of California, San Francisco, San Francisco, CA |
Licenses & Certifications
| 2016 | Medical License - Texas |
| 2009 | American Board of Internal Medicine - Hematology |
| 2009 | American Board of Internal Medicine - Medical Oncology |
| 2009 | Drug Enforcement Administration |
| 2006 | Medical License - New York |
| 2005 | American Board of Internal Medicine - Internal Medicine |
| 2004 | Medical License - California |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - 2025
Associate Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2025
Assistant Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2019
Assistant Professor, Department of Medicine, NYU School of Medicine, New York, NY, 2012 - 2015
Clinical Instructor, Department of Medicine, NYU School of Medicine, New York, NY, 2009 - 2012
Administrative Appointments/Responsibilities
Center Medical Director, MD Anderson Oncology Program at LBJ Hospital, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Chief of Service, LBJ Hospital, Harris Health, Houston, TX, 2017 - 2020
Chief ad interim, Woodhull Medical Center, Brooklyn, NY, 2013 - 2014
Other Professional Positions
Attending Physician, Hematology & Medical Oncology, Metropolitan Hospital Center, New York, NY, 2011 - 2015
Attending Physician, Hematology & Medical Oncology, Bellevue Hospital Center, New York, NY, 2009 - 2015
Attending Physician, Hematology & Medical Oncology, Woodhull Medical Center, Brooklyn, NY, 2009 - 2014
Extramural Institutional Committee Activities
Member, Cancer Survivorship State Advisory Planning Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Clinical Practice Committee, Collaboration for Population Health Innovation and Improvement Cancer Survivorship Workgroup, The University of Texas MD Anderson Cancer Center, 2022 - Present
Co-chair, Harris Health Cancer Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Community Outreach and Engagement For Underserved Texans/Quasi Endowment Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Harris Health Medical Executive Board, The University of Texas MD Anderson Cancer Center, 2020 - Present
Co-chair, Harris Health Pharmacy Hematology/Oncology Subcommittee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Harris Health Pharmacy & Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Harris Health Pharmacy Hematology/Oncology Subcommittee, The University of Texas MD Anderson Cancer Center, 2017 - 2019
Member, LBJ Medical Executive Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Uncompensated Care Advisory Committee & Patient Financial Assistance Workgroup, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Clinical Competency Committee, Hematology/Oncology Fellowship Program, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Harris Health Cancer Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2020
Member, Hematology/Oncology Fellowship Core Faculty, NYU School of Medicine, 2013 - 2015
Member, Cancer Committee, Bellevue Hospital Center, New York, NY, NYU School of Medicine, 2012 - 2015
Member, Admissions Committee, NYU School of Medicine, NYU School of Medicine, 2011 - 2012
Co-founder & Course Director, Genitourinary Tumor Board, Bellevue Hospital Center, New York, NY, NYU School of Medicine, 2011 - 2015
Honors & Awards
| 2023 - 2024 | Teaching Department of the Year, The University of Texas MD Anderson Cancer Center |
| 2020 - Present | Champion of the Quarter, Harris Health |
| 2019 | Grand Prize, Innovation Challenge, American College of Physicians |
| 2019 | President's Recognition of Faculty Excellence Award in Prevention & Outreach, The University of Texas MD Anderson Cancer Center |
| 2018 | Innovator of the Year, Harris Health |
| 2014 - 2015 | Faculty of the Year, Medical Oncology, NYU School of Medicine |
| 2006 - 2007 | Fellow of the Year, Hematology, NYU School of Medicine |
| 1998 - 2002 | Community Service Scholarship, University of California, San Diego |
| 1998 | Jayne Unzelman Memorial Scholarship, University of California, Irvine |
| 1998 - 1999 | Parowski Scholarship, University of California, San Diego |
| 1998 | Medellas Scholarship, University of California, Irvine |
| 1998 | magna cum laude, Bachelor of Science, School of Biological Sciences, University of California, Irvine |
| 1996 | The Barry M. Goldwater Scholarship, University of California, Irvine |
| 1996 - 1998 | Phi Beta Kappa, Phi Beta Kappa |
| 1994 - 1998 | Regents' Scholarship, The University of California |
| 1994 - 1998 | Dean's Honor List, School of Biological Sciences, University of California, Irvine |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2018. Creating and Sustaining a Culture of Quality Improvement: The LBJ Experience. Invited. MD Anderson Institutional Grand Rounds. Houston, TX, US.
- 2017. Locally Advanced Prostate Cancer. Conference. 96th Annual Meeting of the South-Central Section of the American Urologic Association. Naples, FL, US.
- 2017. What Clinical Research Means to You. Conference. The Center for Information & Study on Clinical Research Participation. Houston, TX, US.
- 2015. Healthy Living After a Cancer Diagnosis: Prostate Cancer. Conference. NYU. New York, NY, US.
- 2015. Natural Medicine in Cancer Care. Conference. Bellevue Hospital Center. New York, NY, US.
- 2014. Lenalidomide-induced immune hemolytic anemia: a rare complication of a commonly used myeloma treatment. Poster. Department of Medicine Research Day. New York, NY, US.
- 2013. Cancer Survivorship. Conference. Bellevue Hospital Center. New York, NY, US.
- 2012. Prostate and Colon Cancers: What you need to Know. Conference. DC 37, New York City's Municipal Public Employee Union. New York, NY, US.
National Presentations
- 2024. Exploring underserved cancer survivors' perspectives on survivorship care at community health centers. Poster. AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Los Angeles, CA, US.
- 2024. Clinical Outcomes in Patients with Lymphoma at a Safety-Net Hospital System. Poster. The Summit on Cancer Health Disparities. Seattle, WA, US.
- 2023. Comprehensive Primary Care for Under- and Uninsured Cancer Survivors. Invited. Healthier Texas Summit. Austin, TX, US.
- 2023. Building Capacity for Cancer Survivorship Care: Insights from Healthcare Systems and Community Health Clinics through Interviews and a Peer-to-Peer Telementoring ECHO Approach. Invited. Innovations in Cancer Prevention and Research Conference, Cancer Prevention and Research Institute of Texas. Galveston, TX, US.
- 2023. Enhancing Cancer Survivorship Care Knowledge among Primary Care Clinicians in Community Health Centers. Invited. Annual Cancer Center Survivorship Research Forum: Implementing Equitable Cancer Survivorship Care. Palo Alto, CA, US.
- 2023. Capacity Building of Primary Care Physicians in Cancer Survivorship Care for an Underserved Urban Patient Population: A Project ECHO”, “Developing a Multidisciplinary and Multispecialty Workforce for Patients with Cancer, From Diagnosis to Survivorship: A Workshop”, National Cancer Policy Forum, Global Forum on Innovation in Health Professional Education. Invited. Developing a Multidisciplinary and Multispecialty Workforce for Patients with Cancer, From Diagnosis to Survivorship: A Workshop. Washington, DC, US.
- 2019. A hospital farm: Using urban agriculture to address nutrition, physical activity and food insecurity in cancer survivors. Conference. American Association for Cancer Research (AACR) Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. San Francisco, CA, US.
- 2017. Locally Advanced Prostate Cancer. Conference. 96th Annual Meeting of the South Central Section of the American Urologic Association. Naples, Florida, US.
- 2014. Lenalidomide-induced immune hemolytic anemia: a rare complication of a commonly used myeloma treatment. Poster. 2014 Annual Research Day. New York, New York, US.
Grant & Contract Support
| Date: | 2026 - 2029 |
| Title: | Feasibility Trial of a Mindfulness Meditation Intervention for Patients with Advanced Cancer |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | GRANT14447351 |
| Date: | 2025 - 2030 |
| Title: | Increasing Uptake of Germline Genetic Testing among Prostate Cancer Patients in a Diverse Safety Net Hospital |
| Funding Source: | Cancer Prevention and Research Institute of Texas |
| Role: | Advisor |
| ID: | RP250475-FP00024669 |
| Date: | 2024 - 2027 |
| Title: | Social Isolation, Loneliness, and Heath Outcomes Among Prostate Cancer Survivors |
| Funding Source: | Department of Defense/Congressionally Directed Medical Research Programs (DOD/CDMRP) |
| Role: | Collaborator |
| ID: | GRANT13962866_PC230612 - DoD |
| Date: | 2024 - 2029 |
| Title: | Enhancing Primary Care Capacity for Cancer Survivorship Care Delivery in Community Health Clinics |
| Funding Source: | University of Texas Health Science Center |
| Role: | Collaborator |
| ID: | SA0003818 - FP00020176 |
| Date: | 2023 - 2028 |
| Title: | Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events |
| Funding Source: | National Cancer Institute/National Institutes of Health |
| Role: | Collaborator |
| ID: | FP00016887_Res1 |
| Date: | 2022 - 2024 |
| Title: | The Baylor College of Medicine-MD Anderson-Harris Health Cancer Patient Navigation (CANTO) Collaborative |
| Funding Source: | American Cancer Society |
| Role: | Collaborator |
| ID: | 2023-0075 |
| Date: | 2021 - 2024 |
| Title: | A Technology-Enabled Approach to Enhancing Outpatient Symptom Management |
| Funding Source: | Rising Tide Foundation |
| Role: | Collaborator |
| ID: | 866036 |
| Date: | 2021 - 2025 |
| Title: | Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients from a Safety-Net Healthcare System |
| Funding Source: | Community Outreach and Engagement Fund for Underserved Texans Seed Funding Research or Cancer Control Project Program, MD Anderson |
| Role: | Collaborator |
| ID: | 2022-0383 |
| Date: | 2021 - 2025 |
| Title: | Building a Clinical Trial Network for Texas Community Affiliates |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RFA R-21.2-CTNA |
| Date: | 2021 - 2023 |
| Title: | Improving Survivorship Care for Underserved Cancer Survivors with Multiple Chronic Conditions at Harris Health |
| Funding Source: | UTHealth-MD Anderson Population Health Initiative Collaborative Projects Fund |
| Role: | Collaborator |
| ID: | 2022-0287 |
| Date: | 2019 - 2022 |
| Title: | A phase III study of androgen annihilation in high-risk biochemically relapsed prostate cancer |
| Funding Source: | Alliance Foundation Trials |
| Role: | PI |
| ID: | AFT-19–2018-0265 |
| Date: | 2019 - Present |
| Title: | Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer |
| Funding Source: | Southwest Oncology Group |
| Role: | PI |
| ID: | SWOG 1802 |
| Date: | 2019 - 2020 |
| Title: | Prescription (Rx) for Produce: A Grassroots Medicine, Farm‐to‐Hospital Initiative |
| Funding Source: | American College of Physicians |
| Role: | PI |
| Date: | 2018 - 2019 |
| Title: | LBJ Community Farm: A Public Health Intervention |
| Funding Source: | Texas Medical Center Health Policy Institute |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Raber, M, Love, B, Vazquez, M, Ghosh, C, Rechis, R, Oestman, KB, Ho-Pham, TT, LaRue, D, Walsh, MT, Kizub, DA, Ma, HY, Basen-Engquist, KM. Nutrition Security During Cancer. Cancer Reports 8(2), 2025. e-Pub 2025. PMID: 39948691.
- Kizub DA, Raber M, Baum M, Ma HY, Patel TA, Rechis R, LaRue DM, Ho-Pham TT, Oestman K, Walsh MT Jr, Galvan E, Basen-Engquist K. Patient and Health Care Professional Perspectives on Barriers to and Facilitators of Healthy Eating and Exercise Among Patients With Cancer at a Safety-Net Oncology Clinic: A Qualitative Exploration. JCO Oncol Pract 21(7):OP2400431, 2025. e-Pub 2025. PMID: 39847732.
- Cho, D, Li, Y, Basen-Engquist, KM, Acquati, C, Nguyen, N, Ma, HY, Pettaway, CA, McNeill, LH. Couple-based lifestyle intervention for minority prostate cancer survivors. Annals of Behavioral Medicine 59(1), 2025. e-Pub 2025. PMID: 39945428.
- Jiang, JY, Nze, CC, Guffey, D, Kim, RB, Oluyomi, AO, Rosales, O, Bandyo, R, Miller-Chism, CN, Udden, MM, Mims, MP, Ma, HY, Rivero, GA, Diamond, A, Teegavarapu, PS, Li, A, Flowers, CR. Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system. Blood Neoplasia 1(3), 2024. e-Pub 2024. PMID: 40453060.
- Jiang JY, Nze C, Guffey D, Kim R, Oluyomi AO, Rosales O, Bandyo R, Miller-Chism CN, Udden MM, Mims MP, Ma H, Rivero GA, Diamond A, Teegavarapu PS, Li A, Flowers CR. Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system. Blood Neoplasia 1(3):100020, 2024. e-Pub 2024.
- Lopez-Olivo MA, James J, James J, Krause KJ, Roth M, Palos GR, Ma H, Rodriguez A, Gilmore K, Cinciripini P, Suarez-Almazor ME. A systematic review and meta-analysis of e-cigarette use among cancer survivors. J Cancer Surviv 18(3):1059, 2024. e-Pub 2024. PMID: 36952212.
- Raber M, Rechis R, LaRue DM, Ho-Pham TT, Oestman K, Walsh MT, Kizub D, Ma H, Galvan E, Zhao H, Gonzalez J, Lei X, Hu J, Basen-Engquist K. Enhancing the utilization of healthy living interventions among cancer survivors in historically underserved populations and communities. Cancer Causes Control 34(8):635, 2023. e-Pub 2023. PMID: 37160832.
- Shi JJ, McGinnis GJ, Peterson SK, Taku N, Chen YS, Yu RK, Wu CF, Mendoza TR, Shete SS, Ma H, Volk RJ, Giordano SH, Shih YT, Nguyen DK, Kaiser KW, Smith GL. Pilot study of a Spanish language measure of financial toxicity in underserved Hispanic cancer patients with low English proficiency. Front Psychol 14:1188783, 2023. e-Pub 2023. PMID: 37492449.
- Xu C, Smith GL, Chen YS, Checka CM, Giordano SH, Kaiser K, Lowenstein LM, Ma H, Mendoza TR, Peterson SK, Shih YT, Shete S, Tang C, Volk RJ, Sidey-Gibbons C. Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques. PLoS One 17(8):e0272804, 2022. e-Pub 2022. PMID: 36006909.
- Corrigan, KL, Fu, S, Chen, YS, Kaiser, KW, Roth, M, Peterson, SK, Shih, YT, Jagsi, R, Giordano, SH, Volk, R, Yabroff, KR, Banegas, MP, Acquati, C, Conti, RM, Ma, HY, Ku, K, You, YN, Smith, GL. Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer 128(13):2455, 2022. e-Pub 2022. PMID: 35417565.
- Apostolidou E, Lachowiez C, Juneja HS, Qiao W, Ononogbu O, Miller-Chism CN, Udden M, Ma H, Mims MP. Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System. Clin Lymphoma Myeloma Leuk 21(11):e895-e902, 2021. e-Pub 2021. PMID: 34376374.
- Hu Z, Pan Z, Chen W, Shi Y, Wang W, Yuan J, Wang E, Zhang S, Kurt H, Mai B, Zhang X, Liu H, Rios AA, Ma HY, Nguyen ND, Medeiros LJ, Hu S. Primary Effusion Lymphoma: A Clinicopathological Study of 70 Cases. Cancers (Basel) 13(4):878, 2021. e-Pub 2021. PMID: 33669719.
- Cho D, Basen-Engquist K, Acquati C, Pettaway C, Ma H, Markofski M, Li Y, Canfield SE, Gregg J, McNeill LH. Cultural Adaptation of Evidence-Based Lifestyle Interventions for African American Men With Prostate Cancer: A Dyadic Approach. Am J Mens Health 14(6), 2020. e-Pub 2020. PMID: 33148111.
- Mai B, Wang W, Lin M, Hu S, Wang XI, Chen L, Wahed A, Nguyen A, Ma HY, Medeiros LJ, Hu Z. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients. AIDS 34(12):1735-1743, 2020. e-Pub 2020. PMID: 32889849.
- Cho D, Basen-Engquist K, Acquati C, Ma H, Pettaway C, Li Y, Diep CS, McNeill LH. Study protocol: a lifestyle intervention for African American and Hispanic prostate cancer survivors on active surveillance and their partners. Pilot Feasibility Stud 6:111, 2020. e-Pub 2020. PMID: 32782817.
- Mai B, Wang W, Medeiros LJ, Ma HY, Hu Z. TdT-positive high grade B-cell lymphoma transformed from grade 3B follicular lymphoma in an HIV-positive patient. Pathology 51(7):764, 2019. e-Pub 2019. PMID: 31666176.
- Nusrat M, Parkes A, Kieser R, Hu B, Farhat D, Rieber A, Ma H. Standardizing Opioid Prescribing Practices for Cancer-Related Pain Via a Novel Interactive Documentation Template at a Public Hospital. J Oncol Pract 15(11):e989-e996, 2019. e-Pub 2019. PMID: 31225981.
- King N, Kukreja K, Murzabdillaeva A, Ali Y, Willis J, Maiti A, Ma H, Bull J. A rare presentation of carcinosarcoma of the bone in a young female; response with gemcitabine and docetaxel. Clin Sarcoma Res 9:10, 2019. e-Pub 2019. PMID: 31304003.
- Parkes A, Nusrat M, Di Tomasso PM, Davis L, Ogbonnaya S, Iwuorie M, Patel S, Abraham TG, Mack R, Bhadkamkar NA, Ma H, Nazario LA, Ramondetta L, Rosenstock A, Rieber AG. Successful Implementation of a Multidisciplinary Chemotherapy Efficiency Initiative at a Community Hospital. J Oncol Pract 15(6):e576, 2019. e-Pub 2019. PMID: 30990730.
- Deng W, Yu M, Ma H, Hu LA, Chen G, Wang Y, Deng J, Li C, Tong J, Wang DX. Predictors and outcome of patients with acute respiratory distress syndrome caused by miliary tuberculosis: a retrospective study in Chongqing, China. BMC Infect Dis 20(12):121, 2012. e-Pub 2012. PMID: 22607610.
- Deng J, Wang DX, Deng W, Li CY, Tong J, Ma H. Regulation of alveolar fluid clearance and ENaC expression in lung by exogenous angiotensin II. Respir Physiol Neurobiol 181(1):53-61, 2012. e-Pub 2012. PMID: 22138610.
- Valderrama D, Orsini J, Ma HY. Cerebrovascular Disease as Initial Clinical Presentation in a Patient With Idiopathic Thrombotic Thrombocytopenic Purpura: A Case Report. J Hematol 1(1):23-27, 2012. e-Pub 2012.
- Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13(1):69-80, 2008. e-Pub 2008. PMID: 18167341.
- Fine HA, Kim L, Albert PS, Duic JP, Ma H, Zhang W, Tohnya T, Figg WD, Royce C. A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors. Clin Cancer Res 13(23):7101-6, 2007. e-Pub 2007. PMID: 18056189.
- Sommer JM, Ma H, Wang CC. Cloning, expression and characterization of an unusual guanine phosphoribosyltransferase from Giardia lamblia. Mol Biochem Parasitol 78(1-2):185-93, 1996. e-Pub 1996. PMID: 8813688.
Review Articles
- Chung C, Ma H. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?. Pharmacotherapy 37(9):1052-1072, 2017. e-Pub 2017. PMID: 28654205.
Abstracts
- Romero A, Nguyen S, Ayers AA, Yzquierdo R, McNeill L, Ma H, Overman M, Cerhan JR, Flowers CR, Nze C. Factors Influencing Clinical Trial Participation Among Patients with Non-Hodgkin Lymphoma Receiving Care in a Safety Net Hospital. American Society of Hematology Annual Meeting 144(1), 2024. e-Pub 2024.
- Jackson I, Marleen M, Kizub D, Pabon C, Yzquierdo R, Thomas J, Ayers AA, McNeill L, Ma H, Overman MJ, Flowers C, Nze C. Perception and factors influencing clinical trial participation among racial/ethnic minority breast and colorectal cancer patients. Society for Immunotherapy of Cancer Annual Meeting 12(2), 2024. e-Pub 2024.
- Strong LL, Llavona-Ortiz JY, Ma H, Fernandez ME, Dominguez E, Silva R, Hernandez J, Milbury M. Sources of support and strain in Latino patients with advanced cancer and their family caregivers. AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved 33(9), 2024. e-Pub 2024.
- Balasubramanian BA, Museitif M, Ma H, Lee, S, Walton GH, Shay AL. Exploring underserved cancer survivors' perspectives on survivorship care at community health centers. AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved 33(9), 2024. e-Pub 2024.
- Ludford K, Awad E, Lankford AR, Ma HY, You YN. Implementation of universal germline testing in underserved patients with young onset gastrointestinal cancer. ASCO Annual Meeting 42(16), 2024. e-Pub 2024.
- Museitif M, Balasubramanian BA, Ma H, Eary R. Enhancing knowledge of cancer survivorship care among primary care clinicians serving underserved populations: Lessons from an ECHO project. AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved 32(12), 2023. e-Pub 2023.
- Museitif M, Balasubramanian BA, Ma H, Eary R. Engaging Primary Care Clinicians in Cancer Survivorship Care: Insights from a Pilot Project ECHO in Community Health Clinics. North American Primary Care Research Group Annual Meeting 21(3), 2023. e-Pub 2023.
- Hui D, Puac V, Shelal Z, Dev R, Hanneman S, Jennings K, Ma HY, Urbauer DL, Shete S, Fossella FV, Liao ZX, Blumenschein GR, Chang JY, O'Reilly M, Gandhi S, Tsao AS, Mahler D, Bruera E. Alleviating breathlessness in patients with cancer with dexamethasone (ABCD): A parallel-group, double-blind, randomized clinical trial (RCT). ASCO Annual Meeting 40(16), 2022. e-Pub 2022.
- Hester RH, Farmer LL, Goswamy RV, Chen N, Lee SS, Sember Q, Khwaja R, Dash A, Nguyen D, Haddad CS, Wiele AJ, Ma HY. Improving oral chemotherapy compliance and documentation in a safety-net oncology clinic. ASCO Quality Care Symposium 39(28), 2021. e-Pub 2021.
- Wiele A, Patel TA, Rizvi S, De Los Rios P, Russo K, Smith D, Hester R, Ma HY, Rieber A. Patient experiences and opinions using teleoncology in a safety-net hospital during the COVID-19 pandemic. AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved 29(12), 2020. e-Pub 2020.
- Wiele AJ, Patel TA, Russo K, Rizvi S, De Los Rios P, Hester RH, Smith-Graziani DJ, Ma HY, Rieber AG. Implementing teleoncology in a safety-net hospital during the COVID-19 pandemic. ASCO Quality Care Symposium 38(29), 2020. e-Pub 2020.
- Ma HY, Mody AP, Lustgarten J, Ronning L, Verm R, Garcia-Prats T, Seitzinger M. A hospital farm: Using urban agriculture to address nutrition, physical activity and food insecurity in cancer survivors. American Association for Cancer Research (AACR) Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved 29(6), 2020. e-Pub 2020.
- Wiele A, Ajufo H, Gulvin JM, Laccetti AL, Brown S, Stapleton L, Rizvi S, Park A, Ma HY, Rieber AG. Establishing a prostate cancer referral pathway between urology and medical oncology at Lyndon B. Johnson Hospital. ASCO Quality Care Symposium 37(27), 2019. e-Pub 2019.
- Gulvin JM, Pass S, De Los Rios P, Ma H, Rieber AG. Using a Pedigree-based Questionnaire to Improve Efficiency in a General Oncology Genetics Clinic. ASCO Quality Care Symposium 36(30), 2018. e-Pub 2018.
- Nusrat M, Parkes A, Hu B, Rieber A, Ma H. Standardizing opioid prescribing practices for cancer-related pain via a novel interactive documentation template at a public hospital. ASCO Palliative and Supportive Care in Oncology Symposium, 2017. e-Pub 2017.
- Rangel M, Ma HY, Basen-Engquist K. Disparities in completion of physical activity program for sedentary breast cancer survivors. American Society of Preventive Oncology Annual Meeting, 2017. e-Pub 2017.
- Seetharamu N, Ma HY, Smeltz R, Schindewolf J, Empalmado M, Cohen SE. Medical repatriation at end of life: Barriers, facilitation, and fulfillment - A case-series study at a New York public hospital. ASCO Palliative Care in Oncology Symposium 32(31), 2014. e-Pub 2014.
- Mo L, Deng FM, Chachoua A, Huang WC, Ma HY, Lopez H, Huang C, Wu XR. Novel Role of X-linked Inhibitor of Apoptosis Protein (XIAP) in Bladder Cancer Cell Invasion and Prediction of Disease Progression. ASCO Annual Meeting 32(15), 2014. e-Pub 2014.
- Ma HY, Newman E, Ryan T, Miller G, Sarpel U, Pachter HL, Cohen DJ, Choi H, Goldberg JD, Hochster HS. Neoadjuvant therapy of gastric cancer with cetuximab added to both irinotecan and cisplatin, followed by surgical resection and adjuvant chemoradiation. ASCO Annual Meeting 27(15), 2009. e-Pub 2009.
- Yuan Y, Ma H, Cohen D, Ryan T, Choi H, Love E, Ford KS, Mauro D, Hochster HS. Activity and Tolerance of Bi-weekly CapeOx-Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer and K-ras influences. ASCO Gastrointestinal Cancers Symposium, 2009. e-Pub 2009.
- Ma HY, Ryan T, Newman E, Cohen DJ, Choi H, Hochster HS. Neoadjuvant therapy of gastric cancer with irinotecan, cisplatin and cetuximab followed by surgical resection and adjuvant chemoradiation. ASCO Gastrointestinal Cancers Symposium, 2009. e-Pub 2009.
- Cohen D, Ma H, Yuan Y, Hochman T, Hochster HS. Biweekly cetuximab, oxaliplatin, and capecitabine in first line therapy of metastatic colorectal cancer: Preliminary results on toxicity and K-ras status. ASCO Annual Meeting 26(15), 2008. e-Pub 2008.
- Millett TJ, Craddock Lee SJ, Craig DW, Eary R, Shay LA, Valerio-Shewmaker M, Ghost S, Lineberry M, Rajan S, Ma H, Balasubramanian BA. Implementation determinants of cancer survivorship care coordination in Texas primary care community health centers. Annual Conference on the Science of Dissemination and Implementation in Health.
- Ma H, Rangel M, Basen-Engquist K. The effect of race/ethnicity and insurance status on physical functioning and quality of life outcomes after a structured program to increase physical activity in breast cancer survivors. State of the Science Cancer Survivorship Research Symposium, MD Anderson.
- Strong LL, Llavona-Ortiz JY, Ma H, Fernandez ME, Dominguez E, Hernandez J, Silva R, Milbury M. Sources of support and strain in Latino patients with advanced cancer and their family caregivers. Advancing the Science of Cancer in Latinos.
- Laffoon K, Raber M, Baum M, Vazquez Velazquez M, LaRue D, Ma H, Ho-Pham T, Rechis R, Basen-Engquist K. Examining the perspectives of healthcare teams on the implementation of a hospital-based food prescription program for safety net cancer patients. American Society of Preventive Oncology Annual Meeting.
- Llavona-Ortiz J, Milbury K, Ma H, Hernandez J, Silva R, Dominguez E, Fernandez ME, Strong LL. Formative research to adapt a mindfulness-based intervention for Latino cancer patients and their family caregivers. Society of Behavioral Medicine Annual Meeting.
- Mejia MC, Ma HY, Lowenstein LM, Spooner KK, Duhon G, Douglas EE, Volk RJ. Readiness to Implement Lung Cancer Screening Among Health Care Professionals from a Safety-Net Healthcare System in the U.S. International Shared Decision Making Conference.
- Howell S, Pisters L, Ward J, Karam J, Canfield S, McCarty M, Dhanani N, Chiao E, Ma H, Gregg JR. Demographic and treatment differences among Hispanic and non-Hispanic men with testicular cancer in a county health system. Annual Meeting of South Central Section of American Urological Association.
Book Chapters
- Ma H, Patel TA, Hui D. Oncology. In: Approach to Internal Medicine: A Resource Book for Clinical Practice (Fifth Edition). Springer Cham, 2022.
Patient Reviews
CV information above last modified September 16, 2025